These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35401814)

  • 1. MicroRNA loaded edible nanoparticles: an emerging personalized therapeutic approach for the treatment of obesity and metabolic disorders.
    Campolo F; Catanzaro G; Venneri MA; Ferretti E; Besharat ZM
    Theranostics; 2022; 12(6):2631-2634. PubMed ID: 35401814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in Obesity and Related Metabolic Disorders.
    Landrier JF; Derghal A; Mounien L
    Cells; 2019 Aug; 8(8):. PubMed ID: 31404962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs and other non-coding RNAs in adipose tissue and obesity: emerging roles as biomarkers and therapeutic targets.
    Lorente-Cebrián S; González-Muniesa P; Milagro FI; Martínez JA
    Clin Sci (Lond); 2019 Jan; 133(1):23-40. PubMed ID: 30606812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer.
    Zhang M; Viennois E; Prasad M; Zhang Y; Wang L; Zhang Z; Han MK; Xiao B; Xu C; Srinivasan S; Merlin D
    Biomaterials; 2016 Sep; 101():321-40. PubMed ID: 27318094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue and circulating microRNAs as biomarkers of response to obesity treatment strategies.
    Catanzaro G; Filardi T; Sabato C; Vacca A; Migliaccio S; Morano S; Ferretti E
    J Endocrinol Invest; 2021 Jun; 44(6):1159-1174. PubMed ID: 33111214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicles: Novel Mediators of Cell Communication In Metabolic Disease.
    Huang-Doran I; Zhang CY; Vidal-Puig A
    Trends Endocrinol Metab; 2017 Jan; 28(1):3-18. PubMed ID: 27810172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of exosome-associated microRNA in diagnostic and therapeutic applications to metabolic disorders.
    Yao ZY; Chen WB; Shao SS; Ma SZ; Yang CB; Li MZ; Zhao JJ; Gao L
    J Zhejiang Univ Sci B; 2018 Mar.; 19(3):183-198. PubMed ID: 29504312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to use microRNAs as therapeutic targets.
    Krützfeldt J
    Best Pract Res Clin Endocrinol Metab; 2016 Oct; 30(5):551-561. PubMed ID: 27923450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Insight into the Interaction between Epigenetics and Leptin in Metabolic Disorders.
    Wróblewski A; Strycharz J; Świderska E; Drewniak K; Drzewoski J; Szemraj J; Kasznicki J; Śliwińska A
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31408957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrinsic and Intrinsic Immunometabolism Converge: Perspectives on Future Research and Therapeutic Development for Obesity.
    Caslin HL; Hasty AH
    Curr Obes Rep; 2019 Sep; 8(3):210-219. PubMed ID: 30919312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sperm microRNA Content Is Altered in a Mouse Model of Male Obesity, but the Same Suite of microRNAs Are Not Altered in Offspring's Sperm.
    Fullston T; Ohlsson-Teague EM; Print CG; Sandeman LY; Lane M
    PLoS One; 2016; 11(11):e0166076. PubMed ID: 27814400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging roles and mechanisms of exosomal non-coding RNAs in the mutual regulation between adipose tissue and other related tissues in obesity and metabolic diseases.
    Pan S; Chen Y; Yan J; Li F; Chen X; Xu X; Xing H
    Front Endocrinol (Lausanne); 2022; 13():975334. PubMed ID: 36060952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in metabolism and metabolic disorders.
    Rottiers V; Näär AM
    Nat Rev Mol Cell Biol; 2012 Mar; 13(4):239-50. PubMed ID: 22436747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in dysfunctional adipose tissue: cardiovascular implications.
    Icli B; Feinberg MW
    Cardiovasc Res; 2017 Jul; 113(9):1024-1034. PubMed ID: 28505257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA in cardiometabolic health and disease: The perspectives of sex, gender and personalised medicine.
    Ministrini S; Padro T
    Eur J Clin Invest; 2024 Jul; 54(7):e14223. PubMed ID: 38623918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promises of Nanotherapeutics in Obesity.
    Ash GI; Kim D; Choudhury M
    Trends Endocrinol Metab; 2019 Jun; 30(6):369-383. PubMed ID: 31126754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of miRNA in obesity and insulin resistance: a review.
    Estrella Ibarra P; García-Solís P; Solís-Sáinz JC; Cruz-Hernández A
    Endokrynol Pol; 2021; 72(1):73-80. PubMed ID: 33749820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of long non-coding RNAs in adipose tissue metabolism and associated pathologies.
    Corral A; Alcala M; Carmen Duran-Ruiz M; Arroba AI; Ponce-Gonzalez JG; Todorčević M; Serra D; Calderon-Dominguez M; Herrero L
    Biochem Pharmacol; 2022 Dec; 206():115305. PubMed ID: 36272599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coffee-Derived Exosome-Like Nanoparticles: Are They the Secret Heroes?
    Kantarcıoğlu M; Yıldırım G; Akpınar Oktar P; Yanbakan S; Özer ZB; Yurtsever Sarıca D; Taşdelen S; Bayrak E; Akın Balı DF; Öztürk S; Akçalı KC; Ezer Ü; Kürekçi AE
    Turk J Gastroenterol; 2023 Feb; 34(2):161-169. PubMed ID: 36262101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.